CLOROX CO /DE/ (CLX) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-05

Key Insights

Director Pierre R Breber purchased 5,000 shares of CLX at a weighted average price of $85.82 on 05/05/2026, executed across multiple trades ranging from $85.19 to $86.01, indicating measured accumulation rather than aggressive buying.
Breber's total beneficial ownership after the transaction stands at 18,000 shares held indirectly through a trust, suggesting a significant long-term stake in the company as a board director.
The purchase represents a modest insider investment of approximately $429,124, which is a positive signal of insider confidence but not a substantial buying commitment that would indicate major bullish expectations.
As a director (not an officer), Breber's transaction does not trigger heightened scrutiny under Form 4 requirements, though the execution method with multiple trades demonstrates careful transaction execution.

Want the newest filings?

This analysis covers the filing from 2026-05-05. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-03

Luc Bellet, the EVP and Chief Financial Officer of Clorox Co, sold 244 shares of the company's common stock on April 1, 2026 at a price of $103.63 per share.
Following the reported transaction, Bellet now beneficially owns 20,638 shares of Clorox, down from 20,882 shares previously.
The share sale was due to the withholding of shares by the company to satisfy tax obligations applicable to the vesting of restricted stock.

Filed: 2026-04-02

The reporting person, Christopher J. Williams, has acquired additional Deferred Stock Units in Clorox (CLX) through dividend reinvestment and as compensation for his role as a Director.
The acquired Deferred Stock Units will be settled 100% in Clorox common stock upon Williams' retirement or other termination of service as a Director.
The increase in Deferred Stock Unit holdings suggests Williams' continued commitment to Clorox and confidence in the company's long-term prospects.

Filed: 2026-04-02

The reporting person, Russell J. Weiner, acquired 172.363 deferred stock units through dividend reinvestment and 325.6779 deferred stock units in lieu of director's fees, indicating increased ownership stake in the company.
The deferred stock units will be settled 100% in Clorox stock upon the reporting person's retirement or other termination of service as a director, suggesting a long-term investment perspective.
The reporting person's ownership of deferred stock units has increased to 18,004.0034, indicating a significant and growing economic interest in Clorox's performance.

Filed: 2026-04-02

Insider Matthew J. Shattock, a director of Clorox, has increased his beneficial ownership of the company's stock through the acquisition of additional deferred stock units.
The deferred stock units were acquired through dividend reinvestment and in lieu of quarterly director's fees, indicating that Shattock is committed to the long-term growth of Clorox.
Shattock's increased stake in the company suggests he has a positive outlook on Clorox's future prospects and aligns his interests with those of other shareholders.

Filed: 2026-04-02

The reporting person, Pierre R. Breber, acquired additional deferred stock units (DSUs) in Clorox Co (CLX) through dividend reinvestment and director fee payments, indicating their continued investment in the company.
The total number of DSUs beneficially owned by the reporting person increased from 2,774.3895 to 3,100.0674, suggesting an increased ownership stake in the company.
The acquisition of DSUs is a common practice for directors, as they are often compensated in the form of equity-based awards that are settled in the company's common stock upon retirement or termination of service.

Filed: 2026-04-02

Stephanie Plaines, a director of Clorox Co, has acquired additional deferred stock units through dividend reinvestment and director's fee payments, indicating their continued confidence in the company.
The reporting of these transactions provides transparency into the insider ownership and sentiment at Clorox.
The acquisition of these shares aligns the director's interests with those of shareholders, as the deferred stock units will be settled in Clorox's common stock upon retirement or termination of service.

Filed: 2026-03-17

The reporting person, Chris T. Hyder, an EVP-Group President of Health & Hygiene at Clorox Co, disposed of 41 shares of common stock through a withholding to satisfy tax obligations related to the vesting of restricted stock.
Following the reported transaction, Hyder now beneficially owns 34,969 shares of Clorox Co common stock, indicating continued ownership and commitment to the company.
The transaction was made on March 13, 2026, which is the date of the earliest transaction reported in the filing.

Filed: 2026-03-17

The reporting person, Stacey Grier, is an EVP and Executive Chief of Staff at Clorox Co, indicating that this is a high-level insider transaction.
Grier disposed of 32 shares of Clorox common stock at $108.73 per share, likely to cover tax obligations related to vesting of restricted stock.
The transaction is relatively small, representing a minor change in Grier's overall beneficial ownership of 32,116 Clorox shares.

Filed: 2026-01-05

Gina Boswell, a director of Clorox Co, has received an annual award of 825.0862 deferred stock units as part of the company's 2005 Stock Incentive Plan.
The deferred stock units will be settled 100% in Clorox common stock upon Boswell's retirement or other termination of service as a director.
This filing indicates ongoing management and board-level alignment with Clorox's long-term strategic direction through the granting of equity-based compensation to directors.

Filed: 2026-01-05

The reporting person, Christopher J. Williams, has acquired additional deferred stock units in Clorox Co through dividend reinvestment and director compensation, indicating continued confidence in the company.
The total amount of deferred stock units beneficially owned by the reporting person has increased from 19,685.9816 to 21,596.5756, suggesting a positive long-term outlook.
The reported transactions were made pursuant to the company's stock incentive plan and director compensation policy, which is in line with standard corporate governance practices.

Filed: 2026-01-05

The reporting person, Russell J. Weiner, who is a director of Clorox Co, has acquired 1,637.8577 deferred stock units on 12/31/2025 as an annual award under the 2005 Stock Incentive Plan.
Weiner has also acquired 334.7218 deferred stock units on 12/31/2025 in lieu of receiving quarterly director's fees.
The deferred stock units will be settled 100% in Clorox stock upon Weiner's retirement or other termination of service as a director.

Filed: 2026-01-05

The reporting person, Matthew J. Shattock, acquired 199.1684 deferred stock units through dividend reinvestment and an additional 2,158.5361 deferred stock units through annual awards and director fee payments, indicating increased ownership in the company.
The deferred stock units will be settled 100% in Clorox stock upon the reporting person's retirement or termination of service as a director, suggesting long-term commitment and alignment with shareholder interests.
The reporting of these transactions provides transparency into the director's ownership and demonstrates their ongoing engagement with the company's management and governance.

Other reports for CLOROX CO /DE/

Quarterly Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.